Patent describes methods to automatically generate valid test cases from limited information
Appvance.ai, the inventor and leading provider of AI-driven test automation software announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No: 10,204,035 entitled “SYSTEMS, METHODS AND DEVICES FOR AI-DRIVEN AUTOMATIC TEST GENERATION” which is utilized in the company’s Appvance IQ product. The patent specifically describes first-to-market innovations to automatically generate valid test scripts having limited information about a system and its users. This is Appvance’s fourth issued patent.
AIQ is the leading AI-driven test technology across the world, helping engineering teams make application testing autonomous and continuous as part of their agile and DevOps cycles.
Appvance led the move to AI-driven test generation with several industry firsts:
- 2016: The first self-healing scripts, which improve in each test execution using machine learning (Level 3 autonomy)
- 2017: The first automatically generated data-driven regression tests (1000’s) with no human involvement or scripting (Level 4 autonomy)
- 2018: The first full validation suite which can validate anything humans can, and many tasks no human could do or script, autonomously (Level 5 autonomy)
Appvance IQ’s patented machine learning technologies hold the speed record for legitimate data-driven script creation at 6000 unique scripts created in under 10 minutes. This is several thousand times faster than humans can write test scripts in any language or create using any other test software, with or without Artificial Intelligence.
Appvance IQ is a complete QA creation and execution system that seamlessly integrates with popular tools such as Jenkins, TeamCity, CircleCI, TFS, GIT, Jira and many others to execute deep continuous testing at every build and every deployment. The artificial intelligence capabilities are available today for web-based applications (and mobile web) with all modern libraries (HTML5, AJAX, Angular 1 & 2, React, KendoUI, Polymer, ShadowDOM, VueJS and more.)
Of the $80 billion spent annually on application testing, $78B is spent on people (with some $30B in offshore outsourcing), mostly for manual testing and scripting. Automation has been difficult and time consuming for decades, and test scripts often need as much maintenance as the application does. Appvance IQ disrupts this old model, rendering most scripting and manual testing obsolete, improving test coverage from an average of under 10% to near 100% in certain cases, while driving full QA time to a few hours from days or weeks.
“The issuance of this new AI patent further solidifies our technology lead in one of the most important advances in the IT industry,” said Kevin Surace, CEO of Appvance. “Improving speed, productivity, coverage and costs of software QA is paramount to delivering applications to users that are updated quickly and are as bug free as possible. The breakthroughs our team has accomplished over the years are making that supposed dream a reality for our customers.”
Appvance, in partnership with dozens of enterprises around the world, has measured 90% reductions in QA time (versus scripting, maintaining and manual testing) and 20X improvements in real world test coverage.